Kenneth S. Suslick


Kenneth S. Suslick is the Marvin T. Schmidt Research Professor of Chemistry, Professor of Materials Science & Engineering, and Professor of the Beckman Institute for Advanced Science & Engineering at the University of Illinois at Urbana–Champaign. He is the world's leading expert on the chemical and physical effects of ultrasound and has received numerous awards for his work on sonochemistry and sonoluminescence. Professor Suslick has also introduced new technology in chemical sensing, specifically the use of colorimetric sensor arrays as an optoelectronic nose.

Career

Ken Suslick received his B.S. from the California Institute of Technology in 1974, his Ph.D. from Stanford University in 1978, and came to the University of Illinois at Urbana-Champaign immediately thereafter. He was promoted to full professor at the age of 35, held the first William H. & Janet Lycan Professorship in Chemistry, and then in 2004 became the inaugural Marvin T. Schmidt Professor of Chemistry at the University of Illinois.
Professor Suslick is a Fellow of the National Academy of Inventors, the American Chemical Society, the Royal Society of Chemistry, the Materials Research Society, the Acoustical Society of America, the American Physical Society, and the American Association for the Advancement of Science.
Professor Suslick has more than He has published more than His papers have been cited more than 50,500 times and his h-index is 117, His six most cited papers are listed below.
In addition to his academic research, Professor Suslick has had significant entrepreneurial experience. He was the lead consultant for Molecular Biosystems Inc. and part of the team that commercialized the first echo contrast agent for medical sonography, Albunex™, which became Optison™ by GE Healthcare. In addition, he was the founding consultant for VivoRx Pharmaceuticals and helped invent and commercialize Abraxane™, albumin microspheres with a paclitaxel core, which is the predominant current delivery system for taxol chemotherapy for breast cancer; VivoRx became He then co-founded ChemSensing and its successor companies, and in Mountain View, for the commercialization of the Suslick group's optoelectronic nose technology with particular focus on biomedical applications of this unique sensor technology.

Selected awards and honors

The Suslick Research Group at the University of Illinois at Urbana–Champaign is multi-disciplinary and has worked on three major research areas: the chemical and physical effects of ultrasound ; the mechanochemistry of inorganic solids ; and chemical sensing, molecular recognition, and artificial olfaction, which is a spinoff of earlier work on the bioinorganic and materials chemistry of metalloporphyrins. Of particular interest is the development of the optoelectronic nose, i.e., colorimetric sensor arrays for the detection of VOCs, toxic industrial chemicals, explosives, as well as diverse QA/QC applications for foods and beverages.

Selected works (http://suslick.scs.illinois.edu/publications.html for a complete list of publications with downloadable pdfs, click here)

Regarding sonochemistry:
Regarding sonoluminescence:
Regarding chemical sensing and electronic nose technology:
Regarding mechanochemistry of inorganic solids and Metal-organic framework solids :